Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Heron Therapeutics, Inc. (HRTX) had Weighted-Average Shares Outstanding (Diluted) of 154.02M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$37.20M |
|
$-2.38M |
|
$9.86M |
|
$27.34M |
|
$38.84M |
|
$-1.64M |
|
$-0.74M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-1.64M |
|
$-0.54M |
|
154.02M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
154.02M |
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$210.92M |
|
$13.68M |
|
$21.17M |
|
$232.09M |
|
$258.60M |
|
-- |
|
$0.75M |
|
$259.35M |
|
$-27.26M |
|
$-27.26M |
|
$-27.26M |
|
153.25M |
|
| Cash Flow Statement Financials | |
$-19.74M |
|
$9.61M |
|
$0.84M |
|
$25.80M |
|
$16.52M |
|
$-9.29M |
|
$5.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
-- |
|
-6.43 |
|
73.50% |
|
-4.40% |
|
-4.40% |
|
-- |
|
-6.40% |
|
-6.40% |
|
$-20.00M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.14 |
|
0.47 |
|
193.38 |
|
8.74% |
|
8.74% |
|
-1.03% |
|
8.74% |
|
$-0.18 |
|
$-0.13 |
|
$-0.13 |
|